Cyclin-dependent kinase 5 with phosphorylation of tyrosine 15 residue is enriched in striatal matrix compartment in adult mice

Neuroscience

Volumn 189, Issue , 2011, Pages 25-31

  Morigaki, R ^a,b   Sako, W ^a,b   Okita, S ^a,b   Kasahara, J ^c   Yokoyama, H ^c   Nagahiro, S ^a,b   Kaji, R ^a,b   Goto, S ^a,b  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

C Abl; Cdk5 pS159; Cyclin dependent kinase; Phosphorylation; Striosome

Indexed keywords

CYCLIN DEPENDENT KINASE 5;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME LOCALIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ANIMALS; CORPUS STRIATUM; CYCLIN-DEPENDENT KINASE 5; IMMUNOHISTOCHEMISTRY; MICE; PHOSPHORYLATION; TYROSINE;

EID: 79960905477     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.05.055     Document Type: Article

References (39)

1. Bibb J.A., Chen J., Taylor J.R., Svenningsson P., Nishi A., Snyder G.L., Yan Z., Sagawa Z.K., Ouimet C.C., Nairn A.C., Nestler E.J., Greengard P. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 2001, 410:376-380.
2. Bibb J.A., Snyder G.L., Nishi A., Yan Z., Meijer L., Fienberg A.A., Tsai L.H., Kwon Y.T., Girault J.A., Czernik A.J., Huganir R.L., Hemmings H.C., Nairm A.C., Greengard P. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signaling in neurons. Nature 1999, 402:669-671.
3. Cheng Q., Sasaki Y., Shoji M., Sugiyama Y., Tanaka H., Nakayama T., Mizuki N., Nakamura F., Takei K., Goshima Y. Cdk5/p35 and Rho-kinase mediate ephrin-A5-induced signaling in retinal ganglion cells. Mol Cell Neurosci 2003, 24:632-645.
4. Chergui K., Svenningsson P., Greengard P. Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc Natl Acad Sci U S A 2004, 101:2191-2196.
5. Cheung Z.H., Ip N.Y. The roles of cyclin-dependent kinase 5 in dendrite and synapse development. Biotechnol J 2007, 2:949-957.
6. Crittenden J.R., Cantuti-Castvetri I., Saka E., Keller-McGandy C.E., Hernandez L.F., Kett L.R., Young A.B., Standaert D.G., Graybiel A.M. Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy. Proc Natl Acad Sci U S A 2009, 106:2892-2896.
7. Cyr M., Beaulieu J.-M., Laakso A., Sotnikova T.D., Yao W.-D., Bohn L.M., Gainetdinov R.R., Caron M.G. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proc Natl Acad Sci U S A 2003, 100:11035-11040.
8. Dhariwala F.A., Rajadhyaksha M.S. An unusual member of the Cdk family: Cdk5. Cell Mol Neurobiol 2008, 28:351-369.
9. Dhavan R., Tsai L.-H. A decade of Cdk5. Nat Rev Mol Cell Biol 2001, 2:749-759.
10. Ferrante R.J., Kowall N.W., Beal M.F., Martin J.B., Bird E.D., Richardson E.P. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 1987, 46:12-27.
11. Fu W.Y., Chen Y., Sahin M., Zhao X.S., Shi L., Bikoff J.B., Lai K.O., Yung W.H., Fu A.K., Greenberg M.E., Ip N.Y. Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nat Neurosci 2007, 10:67-76.
12. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 1992, 15:285-320.
13. Goto S., Hirano A., Rojas-Corona R.R. An immunohistochemical investigation of the human neostriatum in Huntington's disease. Ann Neurol 1989, 25:298-304.
14. Goto S., Lee L.V., Munoz E.L., Tooyama I., Tamiya G., Makino S., Ando S., Dantes M.B., Yamada K., Matsumoto S., Shimazu H., Kuratsu J., Hirano A., Kaji R. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann Neurol 2005, 58:7-17.
15. Goto S., Nagahiro S., Kaji R. Striosome-matrix pathology of dystonias: a new hypothesis for dystonia genesis. Dystonia: causes, symptoms and treatment 2010, 1-22. Nova Science Publishers, New York, NY. J. Kurstot, M. Forsstrom (Eds.).
16. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990, 13:244-254.
17. Graybiel A.M. Habits, rituals, and the evaluative brain. Annu Rev Neurosci 2008, 31:359-387.
18. Graybiel A.M., Canales J.J., Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci 2000, 23:S71-S77.
19. Graybiel A.M., Ragsdale C.W. Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci U S A 1978, 75:5723-5726.
20. Greengard P. The neurobiology of slow synaptic transmission. Science 2001, 294:1024-1030.
21. Hedreen J.C., Folstein S.E. Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 1995, 54:105-120.
22. Hisanaga S., Endo R. Regulation and role of cyclin-dependent kinase activity in neuronal survival and death. J Neurochem 2010, 115:1309-1321.
23. Iravani M.M., Syed E., Jackson M.J., Johnston L.C., Smith L.A., Jenner P. A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets. Eur J Neurosci 2005, 21:841-854.
24. Mahmoudi S., Samadi P., Gilbert F., Ouattara B., Morissette M., Grégoire L., Rouillard C., Di Paolo T., Lévesque D. Nur77 mRNA levels and l-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid. Neurobiol Dis 2009, 36:213-222.
25. Meyer D.A., Richer E., Benkovic S.A., Hayashi K., Kansy J.W., Hale C.F., Moy L.Y., Kim Y., O'Callaghan J.P., Tsai L.-H., Greengard P., Nairn A.C., Cowan C.W., Miller D.B., Antich P., Bibb J.A. Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology. Proc Natl Acad Sci U S A 2008, 105:18561-18566.
26. Moratalla R., Quinn B., DeLanney L.E., Irwin I., Langston J.W., Graybiel A.M. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A 1992, 89:3859-3863.
27. Paoletti P., Vila I., Rifé M., Lizcano J.M., Alberch J., Ginés S. Dopaminergic and glutamatergic crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5. J Neurosci 2008, 28:10090-10101.
28. Sako W., Morigaki R., Nagahiro S., Kaji R., Goto S. Olfactory type G-protein α subunit (Gαolf) in the striosome-matrix dopamine systems of adult mice. Neuroscience 2010, 170:497-502.
29. Sasaki Y., Cheng C., Uchida Y., Nakajima O., Ohshima T., Yagi T., Taniguchi M., Nakayama T., Kishida R., Kudo Y., Ohno S., Nakamura F., Goshima Y. Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 2002, 35:907-920.
30. Sato K., Sumi-Ichinose C., Kaji R., Ikemoto K., Nomura T., Nagatsu I., Ichinose H., Ito M., Sako W., Nagahiro S., Graybiel A.M., Goto S. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc Natl Acad Sci U S A 2008, 105:12551-12556.
31. Seto-Ohshima A., Emson P.C., Lawson E., Mountjoy C.Q., Carrasco L.H. Loss of matrix calcium-binding protein-containing neurons in Huntington's disease. Lancet 1988, 4:1252-1255.
32. Sharma P., Sharma M., Amin N.D., Albers R.W., Pant H.C. Regulation of cyclin-dependent kinase 5 activity by phosphorylation. Proc Natl Acad Sci U S A 1999, 96:11156-11160.
33. Smith D.S., Tsai L.-H. Cdk5 behind the wheel: a role in trafficking and transport?. Trends Cell Biol 2002, 12:28-36.
34. Takahashi S., Ohshima T., Cho A., Sreenath T., Iadarola M.J., Pant H.C., Kim Y., Nairn A.C., Brady R.O., Greengard P., Kulkarni A.B. Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc Natl Acad Sci U S A 2005, 102:1737-1742.
35. Tarricone C., Dhavan R., Peng J., Areces L.B., Tsai L.-H., Musacchio A. Structure and regulation of the CDK5-p25nck5a complex. Mol Cell 2001, 8:657-669.
36. Tippett L.J., Waldvogel H.J., Thomas S.J., Hogg V.M., van Roon-Mom W., Synek B.J., Graybiel A.M., Faull R.L. Striosomes and mood dysfunction in Huntington's disease. Brain 2007, 130:206-221.
37. Wilson J.S., Turner B.H., Morrow G.D., Hartman P.J. MPTP produces a mosaic-like pattern of terminal degeneration in the caudate nucleus of dog. Brain Res 1987, 423:329-332.
38. Zhang B., Tan V.B., Lim K.M., Tay T.E. The activation and inhibition of cyclin-dependent kinase-5 by phosphorylation. Biochemistry 2007, 46:10841-10851.
39. Zukerberg L.R., Patrick G.N., Nikolic M., Humbert S., Wu C.-L., Lanier L.M., Gertler F.B., Vidal M., Van Etten R.A., Tsai L.-H. Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 2000, 26:633-646.